0001104659-20-071416.txt : 20200609
0001104659-20-071416.hdr.sgml : 20200609
20200609163344
ACCESSION NUMBER: 0001104659-20-071416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200605
FILED AS OF DATE: 20200609
DATE AS OF CHANGE: 20200609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD
CENTRAL INDEX KEY: 0000941841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 20952273
MAIL ADDRESS:
STREET 1: 375 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10152
FORMER NAME:
FORMER CONFORMED NAME: ROSENWALD LINDSAY MD
DATE OF NAME CHANGE: 19950316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-554-4366
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tm2022118d6_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-06-05
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0000941841
ROSENWALD LINDSAY A MD
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
COMMON STOCK
2020-06-05
4
A
0
24390
0.00
A
262280
D
The 24,390 shares of restricted Common Stock will vest on June 5, 2023, subject to Dr. Rosenwald's continued service on the board on such date.
Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board.
/s/ James F. Oliviero, Attorney-in-Fact
2020-06-09